Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.

Ma WH, Li M, Ma HF, Li W, Liu L, Yin Y, Zhou XM, Hou G.

Life Sci. 2020 Jan 15;241:117139. doi: 10.1016/j.lfs.2019.117139. Epub 2019 Dec 4.

PMID:
31809714
2.

GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.

Zhou XM, Wang GL, Wang XB, Liu L, Zhang Q, Yin Y, Wang QY, Kang J, Hou G.

Front Pharmacol. 2017 Dec 12;8:904. doi: 10.3389/fphar.2017.00904. eCollection 2017.

3.

Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.

Jia L, Sun P, Gao H, Shen J, Gao Y, Meng C, Fu S, Yao H, Zhang G.

J Pharm Pharmacol. 2019 Jun;71(6):1017-1028. doi: 10.1111/jphp.13077. Epub 2019 Mar 7.

PMID:
30847938
4.

Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.

Dong XW, Jia YL, Ge LT, Jiang B, Jiang JX, Shen J, Jin YC, Guan Y, Sun Y, Xie QM.

Toxicology. 2017 Aug 15;389:31-41. doi: 10.1016/j.tox.2017.07.002. Epub 2017 Jul 8.

PMID:
28694203
5.

Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.

Zhao H, Qin HY, Cao LF, Chen YH, Tan ZX, Zhang C, Xu DX.

Toxicol Lett. 2015 Jan 5;232(1):213-20. doi: 10.1016/j.toxlet.2014.10.013. Epub 2014 Oct 18.

PMID:
25455454
6.

Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways.

Tang H, Gao L, Mao J, He H, Liu J, Cai X, Lin H, Wu T.

Cell Stress Chaperones. 2016 Mar;21(2):239-49. doi: 10.1007/s12192-015-0654-4. Epub 2015 Nov 17.

7.

Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice.

Tan ZX, Chen YH, Xu S, Qin HY, Zhang C, Zhao H, Xu DX.

Toxicol Lett. 2016 Jan 5;240(1):161-71. doi: 10.1016/j.toxlet.2015.10.022. Epub 2015 Oct 28.

PMID:
26520185
8.

Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.

Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH.

Int Immunopharmacol. 2014 Oct;22(2):498-504. doi: 10.1016/j.intimp.2014.07.010. Epub 2014 Aug 10.

PMID:
25111852
9.

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.

Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH.

BMC Pharmacol Toxicol. 2018 Apr 2;19(1):13. doi: 10.1186/s40360-018-0204-7.

10.

Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.

Kanemaru R, Takahashi F, Kato M, Mitsuishi Y, Tajima K, Ihara H, Hidayat M, Wirawan A, Koinuma Y, Hayakawa D, Yagishita S, Ko R, Sato T, Harada N, Kodama Y, Nurwidya F, Sasaki S, Niwa SI, Takahashi K.

Lung. 2018 Oct;196(5):531-541. doi: 10.1007/s00408-018-0134-6. Epub 2018 Jun 20.

PMID:
29926178
11.

Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.

Lucattelli M, Fineschi S, Selvi E, Garcia Gonzalez E, Bartalesi B, De Cunto G, Lorenzini S, Galeazzi M, Lungarella G.

Respir Res. 2016 May 6;17(1):49. doi: 10.1186/s12931-016-0373-0.

12.

Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.

Dong SH, Liu YW, Wei F, Tan HZ, Han ZD.

Biomed Pharmacother. 2017 May;89:1297-1309. doi: 10.1016/j.biopha.2017.03.005. Epub 2017 Mar 17.

PMID:
28320097
13.

Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.

Liu Q, Jiang JX, Liu YN, Ge LT, Guan Y, Zhao W, Jia YL, Dong XW, Sun Y, Xie QM.

Toxicol Lett. 2017 May 5;273:1-9. doi: 10.1016/j.toxlet.2017.03.012. Epub 2017 Mar 12.

PMID:
28300665
14.

Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.

Zhu T, Zhang W, Xiao M, Chen H, Jin H.

Int J Mol Sci. 2013 Dec 3;14(12):23581-96. doi: 10.3390/ijms141223581.

15.
16.
17.

Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.

Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA.

Chem Biol Interact. 2015 Jul 25;237:151-65. doi: 10.1016/j.cbi.2015.06.019. Epub 2015 Jun 17.

PMID:
26093215
18.

Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.

Liu Y, Lu F, Kang L, Wang Z, Wang Y.

BMC Pulm Med. 2017 Apr 18;17(1):63. doi: 10.1186/s12890-017-0405-7.

19.

Protective effects of Rosavin on bleomycin-induced pulmonary fibrosis via suppressing fibrotic and inflammatory signaling pathways in mice.

Xin X, Yao D, Zhang K, Han S, Liu D, Wang H, Liu X, Li G, Huang J, Wang J.

Biomed Pharmacother. 2019 Jul;115:108870. doi: 10.1016/j.biopha.2019.108870. Epub 2019 Apr 23.

20.

Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.

Li LF, Kao KC, Liu YY, Lin CW, Chen NH, Lee CS, Wang CW, Yang CT.

J Cell Mol Med. 2017 Nov;21(11):2937-2949. doi: 10.1111/jcmm.13206. Epub 2017 Jun 9.

Supplemental Content

Support Center